FDA NDC Directory · JSON-LD · Markdown

Meropenem

NDC 25021-160 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA216424
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsMEROPENEM (500 mg/20mL)
Marketing started20251101
Package count1

External sources

Source: openFDA. Public-domain (CC0).